Amneal Pharmaceuticals, Inc.AMRXNASDAQ
Loading
Revenue Growth Under PressureDecelerating
Percentile Rank45
3Y CAGR+12.4%
5Y CAGR-18.6%
Year-over-Year Change
Year-over-year revenue growth rate
3Y CAGR
+12.4%/yr
vs -44.8%/yr prior
5Y CAGR
-18.6%/yr
Recent acceleration
Acceleration
+57.2pp
Accelerating
Percentile
P45
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | 8.05% |
| 2024 | 16.73% |
| 2023 | 8.20% |
| 2022 | 5.67% |
| 2021 | 5.08% |
| 2020 | 22.51% |
| 2019 | -2.20% |
| 2018 | 60.88% |
| 2017 | 1.52% |
| 2016 | 17.54% |